Keith Rodvold

12PUBLICATIONS
13CO-AUTHORS
Molecular targetsMicrobial geneticsPharmacogenomicsCross-sectional analysisMedical bacteriology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Aug 27, 2026
Impact of renal impairment on pharmacokinetics, safety, and tolerability of funobactam, combined with imipenem and cilastatin.

|Jun 15, 2026
Plasma and intrapulmonary pharmacokinetics of funobactam, a novel diazabicyclooctane β-lactamase inhibitor, administered in combination with imipenem/cilastatin in healthy subjects.

|Apr 20, 2026
Plasma and intrapulmonary pharmacokinetics of ceftibuten and ledaborbactam in healthy male and female adults.

|Jun 26, 2025
Pivmecillinam for Treatment of Uncomplicated Urinary Tract Infection: New Efficacy Analysis.

Thomas P Lodise, Anita F Das, Niels Frimodt-Møller

|Jun 06, 2025
Plasma and intrapulmonary pharmacokinetics of cefepime and taniborbactam in healthy adult participants.

Keith A Rodvold, Mark H Gotfried, Philip Sabato

|Oct 01, 2024
Intrapulmonary pharmacokinetics of SPR719 following oral administration of SPR720 to healthy volunteers.

Keith A Rodvold, Mark H Gotfried, Xilla T Ussery

Pageof 2

Frequent Collaborators

3 joint publications

Kamal Hamed

2 joint publications

Jianguo Li

1 joint publications

Vipul Gupta

1 joint publications

Thomas P Lodise